Successful kidney transplantation in a patient with preexisting chronic myeloid leukemia treated with imatinib
Ursula Thiem(Johannes Kepler University of Linz), Daniel Cejka(Krankenhaus der Elisabethinen), Gerald Webersinke(AGO Austria), Veronika Buxhofer‐Ausch(Johannes Kepler University of Linz), Wolfgang Kranewitter(AGO Austria), Wolfgang Enkner(Krankenhaus der Elisabethinen)
American Journal of Transplantation
January 1, 2021
Cited by 0
Related Papers
Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study
|Journal of Clinical Oncology|2011|540
Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients
|Blood|2011|448
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study
|The Lancet Haematology|2020|351
Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia
|Blood Cancer Journal|2015|273